Kala Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 57.09. In total, the insiders bought 2.35M and sold 2.28M KALA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
57.09
Buy 2.35M shares
Sell 2.28M shares
55% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
Jun 01, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 57.09.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 30, 2026
Buy
Common Stock
J-Other
Minkowitz Avraham
Chief Executive Officer
CEO / President 0
Value: $0
Jan 30, 2026
Buy
Common Stock
J-Other
Posen Hillel D.
Director 0
Value: $0
Jan 30, 2026
Buy
Common Stock
J-Other
Purdy Brendan P.
Director 0
Value: $0
Jan 30, 2026
Buy
Common Stock
J-Other
Colman Yonatan C.
Director 0
Value: $0
Jan 30, 2026
Buy
Common Stock
J-Other
Berger Chaim D.
Director 0
Value: $0
Dec 18, 2025
Sell
Convertible Loan
J-Other
Lazar David E.
Chief Executive Officer
CEO / President 368 614
Value: $374.9K
Nov 25, 2025
Buy
Common Stock
Oxford Finance Llc
10 Percent Owner
10% Owner 0
Value: $0
Nov 24, 2025
Buy
Series AA Convertible Preferred Stock
A-Award
Lazar David E.
Chief Executive Officer
CEO / President 900 000
Value: $27.8M
Nov 24, 2025
Buy
Common Stock
Lazar David E.
Chief Executive Officer
CEO / President 0
Value: $0
Nov 23, 2025
Buy
Common Stock
Lazar David E.
Chief Executive Officer
CEO / President 0
Value: $0
Nov 09, 2025
Buy
Convertible Loan
Lazar David E.
Chief Executive Officer
CEO / President 368 614
Value: $374.9K
Oct 23, 2025
Sell
Common Stock
S-Sale
Reumuth Mary
Chief Financial Officer
C-Suite Officer 967
Value: $793
Oct 23, 2025
Sell
Common Stock
S-Sale
Iwicki Mark T
Director
Director 154 894
Value: $125.5K
Oct 22, 2025
Sell
Common Stock
S-Sale
Reumuth Mary
Chief Financial Officer
C-Suite Officer 32 230
Value: $26.8K
Oct 22, 2025
Sell
Common Stock
S-Sale
Bazemore Todd
Director
Director 47 768
Value: $39.6K
Oct 22, 2025
Sell
Common Stock
S-Sale
Brazzell Romulus K
See Remarks
Officer 46 748
Value: $38.8K
Oct 22, 2025
Sell
Common Stock
S-Sale
Kharabi Darius
Chief Business Officer
Officer 20 806
Value: $17.3K
Oct 01, 2025
Sell
Common Stock
S-Sale
Baker Bros. Advisors Lp
Former 10% Owner
Other 462 967
Value: $640.7K
Oct 01, 2025
Sell
Common Stock
S-Sale
Baker Bros. Advisors Lp
Former 10% Owner
Other 50 640
Value: $70.1K
Oct 01, 2025
Sell
Common Stock
S-Sale
Baker Bros. Advisors Lp
Former 10% Owner
Other 462 967
Value: $640.7K
Oct 01, 2025
Sell
Common Stock
S-Sale
Baker Bros. Advisors Lp
Former 10% Owner
Other 50 640
Value: $70.1K
Sep 30, 2025
Sell
Common Stock
S-Sale
Baker Bros. Advisors Lp
Former 10% Owner
Other 195 425
Value: $311.9K
Sep 30, 2025
Sell
Common Stock
S-Sale
Baker Bros. Advisors Lp
Former 10% Owner
Other 21 376
Value: $34.1K
Sep 30, 2025
Sell
Common Stock
S-Sale
Baker Bros. Advisors Lp
Former 10% Owner
Other 21 376
Value: $34.1K
Sep 30, 2025
Sell
Common Stock
S-Sale
Baker Bros. Advisors Lp
Former 10% Owner
Other 195 425
Value: $311.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT KALA PHARMACEUTICALS INC
Kala Pharmaceuticals
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE